Cargando…

Nanoscale Peptide Self-assemblies Boost BCG-primed Cellular Immunity Against Mycobacterium tuberculosis

Bacillus Calmette-Guerin (BCG) is the only vaccine against TB and has limited protection efficacy, which wanes past adolescence. Multifunctional CD8+ T cells (IFN-γ+/TNF-α+/IL-2+) are associated with lower reactivation risk and enhanced control of active Mtb infection. Since boosting with BCG is con...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chesson, Charles B., Huante, Matthew, Nusbaum, Rebecca J., Walker, Aida G., Clover, Tara M., Chinnaswamy, Jagannath, Endsley, Janice J., Rudra, Jai S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6104033/ https://www.ncbi.nlm.nih.gov/pubmed/30131591 http://dx.doi.org/10.1038/s41598-018-31089-y

Ejemplares similares

Self-adjuvanting nanovaccines boost lung-resident CD4(+) T cell immune responses in BCG-primed mice
por: Files, Megan A., et al.
Publicado: (2022)

Supramolecular Peptide Nanofibers Engage Mechanisms of Autophagy in Antigen-Presenting Cells
por: Rudra, Jai S., et al.
Publicado: (2017)

Recombinant AhpC antigen from Mycobacterium bovis boosts BCG-primed immunity in mice
por: DÜZENLİ, Özgün Fırat, et al.
Publicado: (2021)

Small Animal Model of Post-chemotherapy Tuberculosis Relapse in the Setting of HIV Co-infection
por: Huante, Matthew B., et al.
Publicado: (2020)

Recombinant BCG-Prime and DNA-Boost Immunization Confers Mice with Enhanced Protection against Mycobacterium kansasii
por: Komine-Aizawa, Shihoko, et al.
Publicado: (2021)

The HyVac4 Subunit Vaccine Efficiently Boosts BCG-Primed Anti-Mycobacterial Protective Immunity
por: Billeskov, Rolf, et al.
Publicado: (2012)

Protection against tuberculosis achieved by dissolving microneedle patches loaded with live Mycobacterium paragordonae in a BCG prime-boost strategy
por: Lee, Mi-Hyun, et al.
Publicado: (2023)

Advancing our understanding of HIV co-infections and neurological disease using the humanized mouse
por: Endsley, Janice J., et al.
Publicado: (2021)

A Mycobacterium bovis BCG-Naked DNA Prime-Boost Vaccination Strategy Induced CD4(+) and CD8(+) T-Cell Response against Mycobacterium tuberculosis Immunogens
por: Lu, Miao, et al.
Publicado: (2014)

Priming with a Recombinant Pantothenate Auxotroph of Mycobacterium bovis BCG and Boosting with MVA Elicits HIV-1 Gag Specific CD8(+) T Cells
por: Chapman, Rosamund, et al.
Publicado: (2012)

Boosting BCG-primed responses with a subunit Apa vaccine during the waning phase improves immunity and imparts protection against Mycobacterium tuberculosis
por: Nandakumar, Subhadra, et al.
Publicado: (2016)

Nanomaterials-based vaccines to target intracellular bacterial pathogens
por: Files, Megan A., et al.
Publicado: (2022)

Commentary: Bettering BCG: a tough task for a TB vaccine?
por: Srivastava, Brahm S., et al.
Publicado: (2019)

Recombinant HBHA Boosting Effect on BCG-Induced Immunity against Mycobacterium tuberculosis Infection
por: Guerrero, G. G., et al.
Publicado: (2011)

Protease-Based Subunit Vaccine in Mice Boosts BCG Protection against Mycobacterium tuberculosis
por: Junqueira-Kipnis, Ana Paula, et al.
Publicado: (2022)

Self-Assembly of Block Heterochiral Peptides into Helical Tapes
por: Clover, Tara M., et al.
Publicado: (2020)

Resolving the nanoscale structure of β-sheet assemblies using single-molecule orientation-localization microscopy
por: Zhou, Weiyan, et al.
Publicado: (2023)

Prime Vaccination with Chitosan-Coated Phipps BCG and Boosting with CFP-PLGA against Tuberculosis in a Goat Model
por: Contreras-Magallanes, Yesenia Guadalupe, et al.
Publicado: (2021)

Prime–Boost with Mycobacterium smegmatis Recombinant Vaccine Improves Protection in Mice Infected with Mycobacterium tuberculosis
por: Junqueira-Kipnis, Ana Paula, et al.
Publicado: (2013)

Heterologous prime-boost BCG with DNA vaccine expressing fusion antigens Rv2299c and Ag85A improves protective efficacy against Mycobacterium tuberculosis in mice
por: Wu, Juan, et al.
Publicado: (2022)

Protection against highly pathogenic SIV by BCG-SIV recombinant priming and attenuated replicating vaccinia-SIV recombinant boosting
por: Zhang, X, et al.
Publicado: (2012)

Heterologous Boosting With Listeria-Based Recombinant Strains in BCG-Primed Mice Improved Protection Against Pulmonary Mycobacterial Infection
por: Liu, Si-Jing, et al.
Publicado: (2020)

Reactivation of immune responses against Mycobacterium tuberculosis by boosting with the CpG oligomer in aged mice primarily vaccinated with Mycobacterium bovis BCG
por: Taniguchi, Keiichi, et al.
Publicado: (2013)

Long-term protective efficacy with a BCG-prime ID93/GLA-SE boost regimen against the hyper-virulent Mycobacterium tuberculosis strain K in a mouse model
por: Kwon, Kee Woong, et al.
Publicado: (2019)

Distant metastasis facilitated by BCG: spread of tumour cells injected in the BCG-primed site.
por: Ishibashi, T., et al.
Publicado: (1980)

Safety and Immunogenicity of Boosting BCG Vaccinated Subjects with BCG: Comparison with Boosting with a New TB Vaccine, MVA85A
por: Whelan, Kathryn T., et al.
Publicado: (2009)

Helper T cell bias following tuberculosis chemotherapy identifies opportunities for therapeutic vaccination to prevent relapse
por: Martinez-Martinez, Yazmin B., et al.
Publicado: (2023)

Intranasal Mucosal Boosting with an Adenovirus-Vectored Vaccine Markedly Enhances the Protection of BCG-Primed Guinea Pigs against Pulmonary Tuberculosis
por: Xing, Zhou, et al.
Publicado: (2009)

Age at Mycobacterium bovis BCG Priming Has Limited Impact on Anti-Tuberculosis Immunity Boosted by Respiratory Mucosal AdHu5Ag85A Immunization in a Murine Model
por: Damjanovic, Daniela, et al.
Publicado: (2015)

Correction: Safety and Immunogenicity of Boosting BCG Vaccinated Subjects with BCG: Comparison with Boosting with a New TB Vaccine, MVA85A
por: Whelan, Kathryn T., et al.
Publicado: (2011)

Successive Intramuscular Boosting with IFN-Alpha Protects Mycobacterium bovis BCG-Vaccinated Mice against M. lepraemurium Infection
por: Guerrero, G. G., et al.
Publicado: (2015)

Airway delivery of both a BCG prime and adenoviral boost drives CD4 and CD8 T cells into the lung tissue parenchyma
por: Kaveh, Daryan A., et al.
Publicado: (2020)

Dual activity of niclosamide to suppress replication of integrated HIV-1 and Mycobacterium tuberculosis (Beijing)
por: Fan, XiuZhen, et al.
Publicado: (2019)

Repeated Aerosolized-Boosting with Gamma-Irradiated Mycobacterium bovis BCG Confers Improved Pulmonary Protection against the Hypervirulent Mycobacterium tuberculosis Strain HN878 in Mice
por: Cha, Seung Bin, et al.
Publicado: (2015)

Vaccination-related Mycobacterium bovis BCG Infection
por: Liberek, Anna, et al.
Publicado: (2006)

Auxotrophic Mycobacterium bovis BCG: Updates and Perspectives
por: Dellagostin, Odir Antônio, et al.
Publicado: (2022)

Heterologous Boost Following Mycobacterium bovis BCG Reduces the Late Persistent, Rather Than the Early Stage of Intranasal Tuberculosis Challenge Infection
por: Wu, Yaqi, et al.
Publicado: (2018)

A multiple T cell epitope comprising DNA vaccine boosts the protective efficacy of Bacillus Calmette–Guérin (BCG) against Mycobacterium tuberculosis
por: Maurya, Sudeep Kumar, et al.
Publicado: (2020)

Boosting BCG with recombinant influenza A virus tuberculosis vaccines increases pulmonary T cell responses but not protection against Mycobacterium tuberculosis infection
por: Muflihah, Heni, et al.
Publicado: (2021)

rBCG Induces Strong Antigen-Specific T Cell Responses in Rhesus Macaques in a Prime-Boost Setting with an Adenovirus 35 Tuberculosis Vaccine Vector
por: Magalhaes, Isabelle, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_sejh7h8lhj4okhmamhbce03h78